IP Verse

Botti patent opposition analysis

The comprehensive analysis of Botti opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Latest patent oppositions filed by Botti

Stay updated with the latest patent oppositions filed by Botti

Patent NumberTitleApplicantOpposition DateOpposition Company
EP4406594
Method Of Synthesizing Thyroid Hormone Analogs And Polymorphs ThereofMADRIGAL PHARMACEUTICALS, INC.Jun 8, 2026BOTTI & FERRARI
EP4340842
Sotorasib Dosing RegimenAMGEN INC.May 26, 2026BOTTI & FERRARI
EP3700529
New Combination Of Active Agents For The Treatment Of Progressive Fibrosing Interstitial Lung Diseases (Pf-Ild)BOEHRINGER INGELHEIM INTERNATIONAL GMBHApr 9, 2026BOTTI & FERRARI
EP4316598
Pharmaceutical Composition Containing Poorly-Soluble Basic MedicineCHUGAI SEIYAKU KABUSHIKI KAISHAMar 17, 2026BOTTI & FERRARI
EP4294395
Treatment Of Breast Cancer Using Combination Therapies Comprising Gdc-9545 And Gdc-0077GENENTECH, INC.Dec 29, 2025BOTTI & FERRARI
EP3615541
Polymorphs And Solid Forms Of (S)-2-((2-((S)-4-(Difluoromethyl)-2-Oxooxazolidin-3-Yl)-5,6-Dihydrobenzo[F]Imidazo[1,2-D][1,4]Oxazepin-9-Yl)Amino)Propanamide, And Methods Of ProductionF. HOFFMANN-LA ROCHE AGDec 19, 2025BOTTI & FERRARI
EP3246047
Combination DrugCHUGAI SEIYAKU KABUSHIKI KAISHASep 24, 2025BOTTI & FERRARI
EP4069254
Combination Decitabine And Cedazuridine Solid Oral Dosage FormsOTSUKA PHARMACEUTICAL CO., LTD.Jun 11, 2025BOTTI & FERRARI
EP3806664
Edible Confectionery Coatings Including Calcium CarbonateWM. WRIGLEY JR. COMPANYFeb 20, 2025BOTTI & FERRARI
EP3595667
Pharmaceutical Compositions Comprising A Jak InhibitorALFASIGMA S.P.A.Sep 17, 2024BOTTI & FERRARI

Top clients of Botti

Top companies who are the clients of Botti

CompanyTotal
BOTTI & FERRARI17
STM5
TACO ITALIA S.R.L.3
SESA1